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Synopsis 
The timely destruction of key regulators through ubiquitin-mediated proteolysis ensures 
the orderly progression of cell cycle. The anaphase-promoting complex (APC) is a major 
component of this degradation machinery and its activation is required for the execution 
of critical events. Recent studies have just begun to reveal the complex control of APC 
through a regulatory network involving WD40 repeat proteins CDC20 and CDH1. Here 
we report on the identification and characterization of human CDH1β, a novel 
alternatively spliced isoform of CDH1. Both CDH1α and CDH1β can bind to APC and 
stimulate the degradation of cyclin B1, but they are differentially expressed in human 
tissues and cells. CDH1α contains a nuclear localization signal which is absent in 
CDH1β. Intracellularly, CDH1α appears in the nucleus while CDH1β is a predominantly 
cytoplasmic protein. The forced overexpression of CDH1α in cultured cells correlates 
with the reduction of nuclear cyclin A, but the steady-state amount of cyclin A does not 
change noticeably in CDH1β-overexpressed cells. In Xenopus embryos, ectopic 
overexpression of human CDH1α, but not of CDH1β, induces cell cycle arrest during the 
first G1 phase at the midblastula transition. Taken together, our findings document the 
differential expression, subcellular localization and cell cycle-regulatory activity of 
human CDH1 isoforms.  
 
Key words: anaphase-promoting complex (APC), CDH1, cell cycle control, alternative 
splicing 
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INTRODUCTION  
The anaphase-promoting complex (APC) is a major cellular ubiquitination system, which 
controls the precise order and timing of eukaryotic cell cycle by targeting mitotic cyclins, 
anaphase inhibitors and other regulators for degradation by proteasome [1,2]. The 
composition of APC is highly conserved in eukaryotes. The APC activity is tightly 
regulated during the cell cycle through phosphorylation and dephosphorylation of its 
subunits [3,4]. In addition, biochemical and genetic analyses in yeast [5,6], fruit flies [7-
9] and frogs [10] have identified homologous proteins CDC20/Fizzy and CDH1/Fizzy-
related/HCT1 as activators and specificity factors of APC. 
CDC20 and CDH1 are members of the WD40 repeat protein superfamily. They bind 
transiently to APC and are thought to facilitate ubiquitination through direct interaction 
with different sets of targets [11,12]. Many of these targets share a recognition motif 
known as D box [13,14]. Distinct motifs termed KEN box [15,16] and A box [17] have 
also been identified in substrate proteins recognized by the CDH1-activated APC.  
The abundance of CDC20 and CDH1 plateaus in G2-M and drops abruptly at the exit 
from mitosis [4,14,18,19]. CDH1 is widely expressed in differentiated tissues including 
postmitotic neurons [20], but its expression is significantly reduced during malignant 
progression of a B-lymphoma cell line [21]. In keeping with this, genetic analysis in C. 
elegans indicates that CDH1 regulates cell proliferation [22]. Both CDC20 and CDH1 
can be phosphorylated [12]. While it remains controversial as to whether phosphorylation 
of CDC20 may stimulate [3], inactivate [23], or have no influence on APC [4], the 
inhibitory phosphorylation of CDH1 has been demonstrated by several groups [3,24,25].  
The APC has emerged as a downstream target of the mitotic checkpoint, which 
prevents the onset of anaphase until all chromosomes are properly aligned [26]. To date, 
more than six components (MAD1, MAD2, MAD3, BUB1, BUB2, and BUB3) of the 
mitotic checkpoint have been identified. Both MAD2 and BUBR1 associate with and 
inhibit CDC20, thereby transducing a stop signal to APC [27]. In addition, yeast BUB2 
and human MAD2B/MAD2L2 can target CDH1 [28-30]. However, the mechanisms by 
which BUBR1, MAD2 and MAD2B inhibit CDC20/CDH1 remain to be elucidated.   
We have previously characterized human MAD1 and MAD2 [31]. Given that CDC20 
and CDH1 are effectors of MAD1 and MAD2, we set out to characterize CDC20 and 
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CDH1 in human cells. In the present study, we identified and characterized a novel 
alternatively spliced isoform of human CDH1. We demonstrated the differential 
expression, subcellular localization and APC-activating activity of the two functional 
isoforms of CDH1 designated CDH1α and CDH1β. Our findings suggest an additional 
level of spatial regulation in the activation of APC.     
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EXPERIMENTAL 
Antibodies  
Rabbit polyclonal anti-CDH1 antibody α-CDH1C was raised against a C-terminal 
peptide (amino acids 472-493 of human CDH1α, underlined in Figure 1A) conjugated to 
keyhole limpet hemocyanin. Rabbit polyclonal anti-CDH1 antibody α-CDH1N was 
raised to a keyhole limpet hemocyanin-conjugated peptide corresponding to the N-
terminus of human CDH1 (amino acids 2-21; underlined in Figure 1A). Mouse 
monoclonal anti-FLAG (M2) was from Sigma. Mouse monoclonal anti-HA (F-7), rabbit 
polyclonal anti-cyclin A (H-432) and rabbit polyclonal anti-CDC27 (H-300) were from 
Santa-Cruz.  
 
RNA and protein analyses  
Human multiple tissue Northern blots (CLONTECH) were probed with a 307-bp 32P-
labeled NcoI-NaeI fragment shared by both CDH1α and CDH1β cDNAs. A 2 kb human 
β-actin cDNA was used as a control for RNA loading. Northern blotting was carried out 
as per manufacturer’s protocol. 
Poly(A)+ RNAs from human whole brain, heart, liver and spleen were purchased from 
CLONTECH. Poly(A)+ RNAs from cultured cells were isolated using the TRIzol reagent 
and oligo(dT) cellulose (Invitrogen). RT-PCR was performed in the presence of 5% 
dimethyl sulfoxide with a reagent kit (Advantage RT-for-PCR from CLONTECH) using 
the manufacturer’s protocol. Synthesis of the first strand cDNA was primed with 
oligo(dT) and random hexamers. Image of ethidium bromide-stained gel was obtained in 
a FOTODYNE gel documentation system. 
HeLa and HepG2 cells were cultured as described [32]. Protein samples from HeLa 
cells were solubilized directly in SDS gel loading buffer (60mM Tris base, 2% SDS, 10% 
glycerol, 5% 2-mercaptoethanol, and 0.1% bromophenol blue), separated on 12% SDS-
PAGE, and electroblotted onto Immobilon-P membrane (Millipore) using a semidry 
blotter (Hoefer). Blots were visualized by chemiluminescence (ECL, Amersham). Co-
immunoprecipitation was performed as previously described [33]. Expression vectors for 
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CDH1α and CDH1β (pHACDH1α and pHACDH1β) were derived from plasmid pHA 
[34].  
 
Luciferase assay 
Luciferase assay was performed as described [35]. Human cyclin B1 cDNA has been 
described [36]. pCYCB1-Luc was derived from reporter plasmid pGL3-Control 
(Promega) and it expresses a luciferase fusion protein with the first 119 amino acid 
residues of cyclin B1 at the N-terminus. Proteasome inhibitor MG-132 (Z-LLL-CHO) 
was purchased from Peptide Institute, Inc. based in Osaka, Japan.  
 
Embryo manipulations  
Eggs were collected from Xenopus laevis females (Xenopus Express, Cape, South 
Africa), which had been injected with 500-700 units of human chorionic gonadotrophin 
(Sigma) 12 hours before egg collection. Eggs were fertilized in vitro with minced testis. 
Embryos were staged as described [37]. RNAs were synthesized and capped with reagent 
kits from Ambion.  
 
Confocal microscopy  
Laser scanning confocal immunofluorescence microscopy was performed on a Zeiss 
Axiophot microscope as previously described [31,32]. Dual labeling was achieved with 
primary antibodies from different species and pre-adsorbed species-specific secondary 
antibodies: Cy5-conjugated goat anti-mouse immunoglobulin G (Zymax) and 
fluorescein-conjugated goat anti-rabbit immunoglobulin G (Zymax). To express a GFP 
fusion protein with peptide sequences encoded by exons 6 and 7 of human CDH1α at the 
C-terminus, we PCR-amplified exons 6 and 7 using primers 5’-CCCAA 
GCTTATTCCCTTAGCAC CAAG  (forward) and 5’-
CGGGATCCCTGGCTGGTACAGGCACT (reverse). The 267-bp fragment was inserted 
into pEGFP-C1 (CLONTECH) via restriction sites HindIII and BamHI. GFP experiments 
were conducted as described [38]. 
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RESULTS 
CDC20 and CDH1 represent two multigene families  
The identification of Drosophila and Xenopus CDH1 [8,10] facilitates the cloning of 
human and mouse orthologs. The isolation and characterization of human CDH1 has 
been reported previously [14,19,39]. In an early and independent attempt to assemble 
full-length CDH1 cDNAs, we also obtained several human and mouse EST clones 
sharing striking sequence homologies with frog CDH1. The human and mouse CDH1 
sequences with a complete coding region were determined and deposited in GenBank 
under accession numbers AF083810 and AF083809 (submitted on August 12, 1998). 
Human and mouse CDH1 proteins (Figure 1A) share 98.4% identity in an overlap of 
493 amino acid residues. The seven WD40 repeats are identical in the two proteins 
except for one E-to-D substitution at the 193rd residue. The nine putative CDK 
phosphorylation sites (shaded in Figure 1A) are also conserved. Since a similarity search 
generated more CDC20-/CDH1-related sequences than expected, we constructed a 
phylogenetic tree of all CDC20/CDH1 homologs from various species (Figure 1B) in 
order to better understand the genetic relationship.    
Notably, there is one additional CDC20 paralog in budding yeast. This protein named 
AMA1/CDC20B (Figure 1B) is required for sporulation and has been implicated as a 
meiosis-specific activator of APC [40]. In fission yeast, five CDC20/CDH1 homologs 
can be identified. In addition to the documented CDC20A (SLP1) and CDH1A 
(SRW1/STE9), two CDC20 paralogs (CDC20B and CDC20C) and another CDH1 
paralog (CDH1B or MFR1 or FZR1) were found. In the phylogenetic tree, the fission 
yeast CDC20B and CDC20C cluster with budding yeast AMA1/CDC20B, while the 
fission yeast CDH1A and CDH1B group with budding yeast CDH1. Interestingly, 
CDH1B/MFR1/FZR1 has been shown to be another meiosis-specific activator of APC 
required for sporulation [41,42]. The bootstrap supports for these clusters are statistically 
very significant (100% or 95%). We postulate that different CDC20/CDH1 homologs in 
fission yeast might serve redundant and non-redundant functions. It would be of interest 
to see how they cooperate to ensure the precise spatiotemporal order of APC activation.     
Multiple CDC20 and CDH1 homologs were also noted in higher eukaryotes (Figure 
1B). Thus Arabidopsis thaliana (thale cress) has at least one CDH1 and three closely 
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related CDC20 homologs (CDC20A, CDC20B, and CDC20C). Likewise, Drosophila 
(fruit fly) possesses CDC20, CDH1/FZR and CDH2/FZR2 [9]. We predict that more 
vertebrate CDC20/CDH1 homologs will be identified as the genome projects progress. 
CDC20 and CDH1 represent two multigene families of WD40 repeat proteins critically 
involved in the regulation of APC. It is important to compare and contrast the functions 
of different CDC20/CDH1-like proteins in one species.   
 
Chromosomal mapping and genomic organization of human CDH1 locus  
We determined the chromosomal map location of human CDH1 gene by sequence 
alignment. Using cDNA information we identified two genomic clones that contain the 
coding and non-coding regions of human CDH1. These were cosmids R33374 and 
R31109 from a genomic library constructed at the Lawrence Livermore National 
Laboratory (GenBank AC005787 and AC005786). Both clones map to chromosome 
19p13.3. The human CDH1 locus (FZR1/ HCDH1) was noted to be closely linked to 
nuclear factor I/C (NFIC) and Sox-like transcription factor (HMG20B or SOXL). This 
map location of CDH1 was confirmed by PCR analysis and by restriction mapping. We 
verified that the distance between NFIC and FZR1 is within 30kb, while the FZR1 and 
HMG20B genes are separated by no more than 37kb (Figure 2A).     
Approximately 43kb of assembled sequence from cosmid R33374 was obtained. 
Human CDH1 locus spans 29.8kb. The sizes of all exons and introns were verified by 
PCR analysis. The gene contains at least 14 exons varying in size from 63bp to 1.4kb 
(Figure 2B). The sequences of all splice junctions and of the 5’ upstream region were 
confirmed by direct sequencing of PCR products amplified from human genomic DNA.  
 
Identification of an alternatively spliced isoform of human CDH1  
We isolated an alternative form of CDH1 from a human heart cDNA library (GenBank 
AF433157). We noted that this cDNA represents an alternatively spliced isoform. This 
novel isoform designated CDH1β can be produced by splicing exon 8 to exon 5, skipping 
exons 6 and 7 (267 nucleotides; Figure 2B). The CDH1β protein lost 89 residues 
containing one WD40 repeat, four CDK phosphorylation sites and a cluster of positively 
charged residues (Figure 1A). This raises the possibility that CDH1β might function or 
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be regulated in a manner different from the original isoform of human CDH1 renamed as 
CDH1α. Noteworthily, CDH1β has been independently isolated by another group 
(GenBank AB013463) and by the Mammalian Gene Collection at the National Institutes 
of Health (http://mgc.nci.nih.gov), suggesting that it is unlikely a cloning artifact or an 
erroneously spliced RNA. 
  
Differential expression of CDH1α and CDH1β  in human tissues and cancer 
cells  
To reassess the expression pattern of CDH1α and CDH1β mRNA and in human tissues 
and cancer cells, we performed Northern blotting (Figure 3A) and RT-PCR (Figure 3, B-
D). CDH1α is the major isoform detected in Northern blot analysis (Figure 3A, 
highlighted by arrows). We did not observe the 2.7-kb CDH1β mRNA in most human 
tissues and cells by Northern blotting with a probe that was expected to hybridize equally 
well to both CDH1α (3.0 kb) and CDH1β (2.7 kb) transcripts (Figure 3A). However, a 
weak band of >2.4 kb in size (highlighted by asterisks) was reproducibly seen in brain 
(Figure 3A, lane 1), HeLa cells (lane 14), and A549 cells (lane 19). This transcript 
possibly derived from CDH1β is much less abundant than the CDH1α mRNA. Using 
antibodies raised against the N-terminal and C-terminal sequences shared by CDH1α (55 
kDa) and CDH1β (45kDa), we can’t detect the 45-kDa CDH1β protein in HeLa and 
HepG2 cells by immunoblotting (data not shown, see Figure 5A below for an example). 
These results implicate CDH1α as a predominant isoform in many tissues and cells. The 
possibly low abundance of CDH1β transcript and protein in cells prompted us to use 
more sensitive and accurate technology for RNA detection. To this end, we tested several 
sets of primers for amplification of human CDH1α and CDH1β in model experiments 
using CDH1α and CDH1β plasmids as template. In our experiments primer sets A and B 
were able to differentially amplify CDH1α and CDH1β. Figure 3B shows that primer set 
A can specifically amplify CDH1α from templates containing either CDH1α alone (lane 
1) or CDH1α plus CDH1β (lane 4). Likewise, primer set B is specific for CDH1β from 
templates containing CDH1β alone (lane 2) or CDH1α plus CDH1β (lane 3). Next, we 
tested RNAs from various human tissues and cells using primer sets A (Figure 3C) and B 
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(Figure 3D). We noted that both CDH1α and CDH1β were detected in multiple sources. 
The CDH1α transcript is relatively more abundant in heart, liver, spleen, HeLa cells, 
HepG2 cells and H1299 cells (Figure 3C). In contrast, the CDH1β mRNA is expressed in 
heart, spleen, and H1299 lung cancer cells (Figure 3D). The identity of the CDH1α and 
CDH1β amplification products was verified by DNA sequencing. Thus, CDH1β can be 
found in some tissues and cells albeit in low abundance. The distinct expression patterns 
of CDH1α and CDH1β suggest that they might serve different and complementary 
functions.       
 
APC-binding and APC-activating activity of CDH1β  in HeLa cells  
While our study is in progress, four CDH1 homologs have been identified in chick [43]. 
All of them bind and activate APC in vitro and in cultured cells. To our surprise, all four 
chicken CDH1 homologs contain sequences corresponding to exons 6 and 7 of human 
CDH1 gene. They represent four different gene loci and were not produced by alternative 
splicing. Thus, none of them are structurally equivalent to human CDH1β. However, 
vertebrate CDH1 variants generated through distinct mechanisms could still be 
functionally related. Based on this reasoning, human CDH1β isoform and chicken CDH1 
homologs could serve similar or related functions intracellularly. To test this hypothesis, 
we asked whether human CDH1β binds to and activates APC in HeLa cells. 
First, we expressed hemagglutinin (HA)-tagged CDH1α and CDH1β proteins in HeLa 
cells. As expected, cells transfected with CDH1α and CDH1β expression plasmids 
produced 55kDa and 45kDa proteins reactive to anti-HA antibody, respectively (Figure 
4A, compare lane 2 to lane 1). This provides the direct evidence that a CDH1β protein 
distinct to CDH1α can be translated from the CDH1β transcript we have identified. We 
next performed co-immunoprecipitation experiments with extracts of CDH1α- and 
CDH1β-expressing cells. Figure 4B shows that the precipitates prepared with an 
irrelevant antibody against the FLAG tag did not contain CDC27, a subunit of the APC 
complex. In contrast, CDC27 was found in the protein complex pulled down by the anti-
HA antibody (Figure 4C). These data suggest that CDH1β associates with CDC27 in 
HeLa cells as tightly as CDH1α (Figure 4C, compare lane 2 to lane 1).        
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To determine whether association of CDH1β with APC leads to activation of 
proteolysis, we constructed a reporter plasmid expressing the firefly luciferase fused to 
the D box of cyclin B1. This plasmid (pCYCB1-Luc), when transfected into cells, can 
reflect the in vivo activity of the APC-dependent ubiquitination and degradation system 
in real time [24,44]. We observed that the overexpression of either CDH1α or CDH1β 
protein significantly increased the degradation of the cyclin B1-luciferase fusion protein 
(Figure 4D). APC-dependent proteolysis is through proteasome. If CDH1α and CDH1β 
specifically target APC, their stimulatory effect on cyclin B1 degradation should be 
responsive to proteasome inhibitors. Indeed, when we incubated the CDH1α- and 
CDH1β-expressing cells with proteasome inhibitor MG-132, the CDH1α-/CDH1β-
induced degradation of cyclin B1-luciferase was prevented (Figure 4D, compare filled 
with unfilled columns). Thus, both CDH1α and CDH1β are specific activators of APC-
dependent and proteasome-mediated destruction of cyclin B1 in HeLa cells.  
 
Differential localization of CDH1α  and CDH1β  
Next we queried for the subcellular localization of CDH1α and CDH1β. We generated 
two specific antisera against CDH1 (α-CDH1N and α-CDH1C, Figure 1A) and stained 
cultured cells using the purified antibodies. As a first step, the specificity of the anti-
CDH1 antibodies was verified by Western blotting. For one example, HepG2 cell lysates 
were probed with either α-CDH1C or α-CDH1C pre-incubated with excessive amount of 
immunizing peptide (Figure 5A). A single protein species corresponding to the 55-kD 
CDH1α was detected from HepG2 cells (Figure 5A, lane 1) and the band was not seen 
with a pre-absorbed serum (lane 2). Then we stained HepG2 cells with either α-CDH1C 
or α-CDH1C pre-absorbed with immunizing peptide. The endogenous CDH1α in HepG2 
cells localized to the nucleus and the specificity of this nuclear staining was corroborated 
by peptide blocking experiment (data not shown). These results generally agree with 
recent findings on the nuclear localization of CDH1 [45,46].  
We were concerned that CDH1β was not detected in Western blotting and 
immunostaining due to the low abundance (Figure 5A). To remedy this and to distinguish 
the CDH1β staining from that of CDH1α, we stained for epitope-tagged CDH1α and 
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CDH1β expressed from exogenously introduced plasmids (Figure 5B). HeLa cells 
transiently transfected with expression plasmids for HA-tagged CDH1α (Figure 5B, 
panels 1 and 2) and CDH1β (panel 3) were stained with α-CDH1N (panel 1) or anti-HA 
(α-HA; panels 2 and 3) antibodies (Figure 5B). These antibodies reacted with HA-
CDH1α/HA-CDH1β in a highly specific manner. Notably, a nuclear localization pattern 
of CDH1α was consistently seen with both α-CDH1N and α-HA. By sharp contrast, 
CDH1β localized homogenously to the cytoplasm (Figure 5B, panel 3). The identity of 
the HA-CDH1β protein was further verified by immunostaining with α-CDH1N and α-
CDH1C. Both antibodies reacted with the overexpressed HA-CDH1β as well as the 
endogenous CDH1α (data not shown).      
Both CDH1α and CDH1β bind to and activate APC (Figure 4), but they localize to 
different subcellular compartments (Figure 5B). In this setting, CDH1α and CDH1β 
could encounter distinct sets of APC substrates at different locales. For example, they are 
able to activate cyclin B1 destruction (Figure 4B) and might cooperate with each other to 
mediate the timely and orderly degradation of nuclear and cytoplasmic cyclin B1. In 
another case, they might act differentially on the nuclear cyclins such as cyclin A and 
cyclin E. To explore how expression of CDH1α and CDH1β might influence the 
proteolysis of cyclin A, we overexpressed HA-CDH1α and HA-CDH1β in HeLa cells 
and co-stained for CDH1 and cyclins (Figure 5C). In agreement with previous studies 
[47], ambient cyclin A is predominantly nuclear (Figure 5C, panels 2 and 5). We 
observed that CDH1α co-localized with cyclin A to the nucleus (Figure 5C, panel 3). In 
addition, the forced overexpression of CDH1α correlated with the reduction of nuclear 
cyclin A (Figure 5C, panel 2, compare cell with an arrow with cells without arrow). This 
observation is generally consistent with reported findings [44]. On the other hand, 
CDH1β and cyclin A were found in different subcellular locations (Figure 5C, panel 6) 
and CDH1β overexpression did not lead to noticeable degradation of cyclin A (panel 5, 
compare cell with an arrow with cells without arrow). These results support the notion 
that human CDH1α and CDH1β fulfill different functions at different locales of the cell. 
 
CDH1α contains a nuclear localization signal which is absent in CDH1β 
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The differential localization of CDH1α and CDH1β (Figure 5) suggests that the peptide 
fragment present in CDH1α but absent in CDH1β might dictate nuclear import. Indeed, a 
cluster of nine positively charged residues can be found in that fragment (Figure 1, 
residues highlighted by “#”). This cluster might act as a nuclear localization signal in 
CDH1α. To test this hypothesis, we fused the peptide sequence encoded by exons 6 and 
7 of CDH1α to green fluorescent protein (GFP). When overexpressed in HeLa cells, GFP 
alone was diffusely found in both the cytoplasm and the nucleus (Figure 6, panel 1). In 
contrast, when we overexpressed the chimeric protein GFPE67 in cells, the heterologous 
GFP protein was targeted into the nucleus by the nuclear localization signal resided 
apparently in the sequences encoded by exons 6 and 7 of CDH1α (Figure 6, panel 2). 
Thus, CDH1α harbors a nuclear localization signal which is absent in CDH1β. 
Identification and further characterization of this nuclear localization signal are reported 
elsewhere [46].   
 
Differential activity of human CDH1α and CDH1β in Xenopus embryos 
The co-localization studies shown above suggest that human CDH1β might be a poor 
activator of the APC-mediated degradation of nuclear cyclin A (Figure 5C). To compare 
the global influence of human CDH1α and CDH1β on cell cycle progression, we used 
the Xenopus embryo microinjection system. We and others have shown that the injection 
of Xenopus CDH1 RNA into one blastomere of two-cell stage Xenopus embryos 
sufficiently induced a cell cycle arrest at the midblastula transition (MBT) due to 
continued activation of APC [30,48]. As such, the overexpression of CDH1 was 
phenotypically silent before the MBT (stage 8.5) and the cell division cycles seemed 
normal. However, immediately after the MBT the cells on the CDH1-injected side were 
significantly larger than those on the uninjected side. Indeed, when we overexpressed 
human CDH1α in early Xenopus embryos by microinjecting CDH1α RNA into one of 
the two blastomeres in stage 2, we observed a post-MBT arrest (Figure 7A, panel 3) 
exactly as described for Xenopus CDH1 (Figure 7B). As shown in a CDH1α-injected 
embryo at late stage 9 (Figure 7A, panel 3), the cells overexpressing CDH1α were more 
than five times bigger, implicating that the inhibition lasted for at least several cycles of 
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cell division. In control groups, the uninjected, mock-injected, and antisense CDH1α-
/CDH1β-injected embryos did not arrest cell division during the MBT (Figure 7A, panels 
1 and 2; Figure 7B). Interestingly, the injection of human CDH1β RNA is phenotypically 
silent (Figure 7A, panel 4 and Figure 7B) and the injected embryos were 
indistinguishable from the controls (Figure 7A, compare panel 4 with panels 1 and 2). 
Thus, human CDH1α and CDH1β have differential APC-activating activity in Xenopus 
embryos. CDH1β is incapable of inducing the post-MBT cell cycle arrest. 
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DISCUSSION 
Here we documented the differential expression, subcellular localization and activity of 
CDH1α and CDH1β, two functional isoforms of human CDH1. CDC20 and CDH1 
represent two multigene families of WD40 repeat proteins that are key regulators of APC 
(Figure 1). A novel alternatively spliced isoform of human CDH1, named CDH1β, was 
identified from a heart cDNA library (Figure 1 and Figure 2). The two CDH1 isoforms 
were expressed to different levels in various human tissues and cells (Figure 3). Both 
isoforms associate with APC subunit CDC27 and stimulate the APC-dependent 
proteolysis of cyclin B1 in cultured cells (Figure 4). CDH1α, which harbors a nuclear 
localization signal absent in CDH1β (Figure 6), localizes to the nucleus (Figure 5). In 
contrast, CDH1β is cytosolic (Figure 5). Finally, CDH1α, but not CDH1β, co-localizes 
with nuclear cyclin A, activates cyclin A degradation, and induces a post-MBT arrest in 
cell cycle progression in Xenopus embryos (Figure 5 and Figure 7). Our work suggests a 
complex spatial and temporal control of APC activation during the cell cycle.   
One salient finding in our study is the differential expression, localization and activity 
of human CDH1α and CDH1β generated through alternative splicing. Alternative 
splicing is very common in human cells and approximately 60% of human genes are 
estimated to have two or more transcripts [49]. Among the various types of alternative 
splicing that give rise to multiple isoforms of a gene, exon skipping can be caused by 
exonic and intronic mutations [50]. In this context, it would be of interest to identify and 
characterize the signals and mechanisms through which the production of CDH1β is 
induced. 
Both CDH1α and CDH1β can bind to the APC complex and activates the APC-
dependent degradation of cyclin B1 in cultured cells (Figure 4). However, the presence of 
CDH1α and CDH1β in different abundance (Figure 3) and at different locales (Figure 5) 
suggests that they might play different roles in cell cycle regulation. In line with this, we 
observed that they showed differential activity in the activation of APC both in cultured 
human cells (Figure 5C) and in Xenopus embryos (Figure 7). As yet the mechanism of 
the differential APC-activating activity of the two isoforms is not fully understood. One 
possibility is that CDH1α and CDH1β may be active on different sets of substrates. We 
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note that some of our data are in support of this model. Thus, both CDH1α and CDH1β 
bind to APC and stimulate the degradation of cyclin B1 (Figure 4). Cyclin B1 shuttles 
between the nucleus and the cytoplasm [47] while the cyclin B1-luciferase fusion protein 
used in this study is both cytoplasmic and nuclear (data not shown). This localization 
pattern is compatible with the observed degradation of cyclin B1 by both CDH1α and 
CDH1β. It is also noteworthy that cyclin B1 destruction also takes place at metaphase 
when the nuclear envelope has been broken down [51]. In this scenario, cyclin B1 and 
possibly other cyclins are accessible to both CDH1α and CDH1β. On the other hand, 
CDH1β is apparently a poor activator of the APC-mediated proteolysis of nuclear cyclin 
A (Figure 5). Plausibly, CDH1α and CDH1β may have differential activity on cyclin A 
and other cell cycle regulators. In this regard, further biochemical analyses are required 
to compare in parallel the ubiquitination-stimulating activity of CDH1α and CDH1β on 
different targets.     
Four CDH1 homologs in chick derived from four different loci have recently been 
documented [43]. These chicken CDH1 homologs share 62%-95% identical amino acid 
residues with human CDH1α, but are differentially expressed and localized. Importantly, 
they exhibit quantitatively different APC-stimulating activity on different substrates [43]. 
These CDH1 homologs are plausibly derived from gene duplications. None of the four 
chicken CDH1 homologs were generated through alternative splicing. Neither were they 
structurally equivalent to human CDH1β identified in this work. Up to date human 
orthologs of the four chicken CDH1 proteins have not been described except for the 
original human CDH1α isoform and another EST clone possibly orthologous to the most 
divergent ChkCDH1-D. With the working draft of human genome sequence available, we 
are still uncertain whether there are four human CDH1 loci corresponding to those in 
chick. It is not impossible that at least some of the gene duplication events leading to the 
production of four CDH1 homologs in chick might have taken place after the separation 
of birds from other vertebrates. On the other hand, it remains to be seen whether CDH1 
isoforms orthologous to human CDH1β exist in other species including chick. 
Nevertheless, our working model is that the various CDH1 isoforms in vertebrates have 
differential activity on different sets of targets. In this regard, gene duplication, which 
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produced four CDH1 homologs in chick, and alternative splicing, which led to the 
formation of human CDH1β, likely represent two major mechanisms by which CDH1 
isoforms could be generated. According to our model, the differential activity of CDH1α 
and CDH1β in Xenopus embryos is attributed to their differential ability to activate the 
degradation of different targets such as cyclin A.                
The subcellular localization pattern (Figure 5B) implicates human CDH1α as a 
nuclear activator of APC. Consistent with this, the forced overexpression of CDH1α in 
the nucleus correlates with the degradation of nuclear cyclin A (Figure 5C). The nuclear 
localization of human CDH1α ensures its accessibility to nuclear regulators and targets 
such as CDC14 [52], Emi1 [53], APC subunits [54] and cyclins [47]. For example, the 
colocalization of CDH1α and cyclin A (Figure 4C) provides the opportunity for the 
suggested regulation of CDH1α-APC by cyclin A [24,55]. In contrast to the nuclear 
pattern of CDH1α, CDC20 resides ambiently in the cytoplasm [18]. Thus, CDC20 and 
CDH1α are activated in different compartments of a cell. This adds another level of 
complexity to the regulation of APC. In another perspective, the steady-state 
localizations of many cell cycle regulatory proteins are determined by the relative rates of 
nuclear import and export, because they shuttle continuously between the nucleus and the 
cytoplasm [47,56,57]. In this regard, it will be of great interest to investigate the dynamic 
nucleocytoplasmic shuttling of CDH1α and CDH1β.   
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FIGURE LEGENDS 
Figure 1   CDC20 and CDH1 represent two families of WD40 proteins. (A) Amino 
acid sequence of human and mouse CDH1. The human sequence is in capital. The mouse 
sequence different from the human is indicated with small letters in brackets lying on the 
top. Sequences of the N-terminal and C-terminal synthetic peptides used to raise antisera 
in rabbits are underlined. Putative CDK phosphorylation sites are shaded. Residues 
absent from alternatively spliced variant CDH1β are boxed. The positively charged 
residues that act putatively as a nuclear localization signal are highlighted by “#”. The 
seven WD40 repeats are indicated. (B) Consensus phylogenetic tree of all CDC20-
/CDH1-related proteins in the extant databases. Phylogenies were inferred from protein 
sequences aligned with the ClustalW program (www.ch.embnet.org/software/clustalw. 
html). Kimura’s distances were computed with the PROTDIST program in the PHYLIP 
package (version 3.573, J. Felsenstein, University of Washington). Tree reconstruction 
was based on the neighbor-joining method (NEIGHBOR). SEQBOOT and CONSENSUS 
programs in the same package were used to perform bootstrap replication and to produce 
the majority rule consensus tree from 100 replicates. Numbers on the nodes are bootstrap 
confidence probabilities (%). GenPept (gp), EMBL (emb), PIR (pir), or SWISS-PROT 
(sp) protein accession numbers of the sequences are: CDC20B-thale cress, gp/AF160760;  
CDC20C-thale cress, pir/T01768; CDC20-rape, emb/CAA11819.1; CDC20A-thale cress, 
gp/AAF14048.1; CDC20-carrot, pir/T14352; CDC20-rat, gp/AAC14741.1; CDC20-
human, gp/AAD16405.1; CDC20-frog, gp/AAC41376.1; CDC20-clam, gp/AAC06232.1; 
CDC20A-fission yeast, pir/T41719; CDC20-budding yeast, gp/BAA03957.1; CDC20-
nematode, pir/T27762; CDC20-trichomonad, gp/AAB51112.1; CDC20B-fission yeast, 
pir/T41034; CDC20C-fission yeast, pir/T41148; AMA1/CDC20B-budding yeast, gp/ 
NP_011741.2; CDH1-mouse, gp/AAD52029.1; CDH1-human, gp/AAC62835.1; CDH1-
frog, emb/CAA74576.1; CDH1-fly, gp/AAF45973.1; CDH1-nematode, pir/T27730; 
CDH2-fly, gp/AAF47111.1; CDH1-barrel medic, gp/AAD22612.1; CDH1-thale cress, 
pir/ T09351; CDH1β-fission yeast, pir/T40614; CDH1α-fission yeast, pir/T37680; 
CDH1-budding yeast, gp/NP_011512.1.  
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Figure 2  Genomic characterization of human CDH1. (A) Schematic delineation of 
human CDH1 at 19p13.3. Arrows underlying the genes indicate orientation of 
transcription. FZR1/HCDH1, human fizzy-related 1 or CDH1; INSR, insulin receptor; 
NF1C, nuclear factor I/C; HMG20B, high mobility group 20B or Sox-like transcription 
factor; Tel, telomeric; Cen, centromeric. (B) Genomic structure of the human CDH1 
gene. Non-coding (open boxes) and coding exons (filled boxes) are shown.  
 
Figure 3   Expression of CDH1 mRNA in human tissues and cells. (A) Northern blot 
analysis of CDH1 mRNA in human tissues and cells. CDH1-specific probe hybridizes to 
a predominant mRNA migrating with a size of ~3 kb (arrow). This size corresponds to 
CDH1α (3.0 kb). A band possibly derived from CDH1β (2.7 kb) is highlighted by 
asterisk (*). The hybridization signal of CDH1β is much weaker (~ 10-fold) than that of 
CDH1α, but it is reproducibly seen in some tissues and cells. β-actin-specific 
hybridization was performed on the same blot after stripping the CDH1α signal in order 
to verify equivalent loadings. Blots were from CLONTECH and all lanes contain ~2 µg 
of polyadenylated RNA. Similar results were obtained with three different probes 
corresponding to the N-terminal, C-terminal, and central parts of CDH1α. (B) Isoform-
specific PCR analysis of CDH1α and CDH1β. The PCR reactions contain the indicated 
primer sets (set A for lanes 1 and 4, and set B for lanes 2 and 3) and templates (plasmid 
pCDH1α for lane 1, pCDH1β for lane 2, and pCDH1α + pCDH1β for lanes 3 and 4). 
Results are representative of triplicate experiments. Sequences for the PCR primers are 
5’-GTG CAG GAC CCG CAG ACT GAG-3’ plus 5’-CTC CGT GTA CTG CTG CAC 
GGG-3’ (primer set A, size of CDH1α amplification product: 740bp), and 5’-GAG GAC 
CGC AGG CTG CAG CCC-3’ plus 5’-CTG CTG CAC GGG GCT CAG GCT CGA-3’ 
(primer set B, size of CDH1β amplification product: 443bp). M: molecular weight 
marker. (C) RT-PCR analysis of CDH1α mRNA in human tissues and cell lines. The 
PCR reactions contain primer set A and total RNAs from the indicated sources (HepG2: 
hepatoma cells, U2 OS: osteosarcoma cells, H1299: lung cancer cells, AGS: gastric 
adenocarcinoma cells, MKN: stomach adenocarcinoma cells, Chang: Chang cells 
possibly established via HeLa cell contaminant). Results are representative of duplicate 
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amplifications of two independent preparations of RNA samples. (D) RT-PCR analysis 
of CDH1β mRNA in human tissues and cell lines. The PCR reactions contain primer set 
B and total RNA from the indicated sources.  
 
Figure 4   Both CDH1α and CDH1β associate with APC and activate APC-
dependent degradation of cyclin B1. (A) Expression of CDH1α and CDH1β in HeLa 
cells. Expression plasmids for HA-tagged CDH1α and CDH1β were transiently into 
cells. Extracts of transfected cells were probed with a monoclonal anti-HA antibody. (B-
C) Co-immunoprecipitation experiments. HeLa cells expressing HA-tagged CDH1α 
(lane 1) and CDH1β (lane 2) were immunoprecipitated with mouse anti-FLAG (panel B) 
or anti-HA (panel C). The precipitates were resolved on SDS-PAGE and the Western 
blots were probed with rabbit anti-CDC27. (D) CDH1α and CDH1β stimulate cyclin B1 
degradation. Cells were co-transfected with pCYCB1-Luc reporter plus empty vector, or 
plus CDH1α expression plasmid, or plus CDH1β expression plasmid. Transfected cells 
were untreated (□) or treated (■) with proteasome inhibitor MG-132 (25 µM) for 12 
hours before harvest.   
 
Figure 5  Differential localization of CDH1α and CDH1β. (A) Western blotting. 
Extracts of HepG2 cells (~20 µg) were resolved by SDS-PAGE. Immunoblotting was 
performed using purified α-CDH1C serum. The position of CDH1α (55 kDa) is 
highlighted. The α-CDH1C antibody was purified through a HiTrap NHS-activated 
affinity column (Pharmacia) coupling to the immunizing peptide. A duplicate blot was 
separately probed with α-CDH1C pre-incubated with 3µg of immunizing peptide (-α-
CDH1C w/ pep.; lane 2). Similar results were obtained using another antibody α-CDH1N 
raised against the N-terminal sequences shared by CDH1α and CDH1β (data not shown). 
(B) Subcellular localization of exogenously expressed CDH1α and CDH1β in HeLa 
cells. Cells were transfected respectively with expression vectors pHACDH1α (panels 1 
and 2) and pHACDH1β (panel 3), in which the expression of HA-tagged 
CDH1α/CDH1β is driven by the SV40 promoter. Cells were fixed 36 hours after 
transfection and stained with α-CDH1N (panel 1) or α-HA (panels 2 and 3) antibodies. 
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The same fields of the cells were also monitored by phase contrast microscopy (panel 1’, 
2’ and 3’). vec.: expression vector. ab.: antibody. Bar, 20µm. The patterns shown in 
panels 2 and 3 are representative of 85% and 79%, respectively, of 200 CDH1α-
/CDH1β-expressing cells. (C) Differential co-localization of CDH1α and CDH1β with 
cyclin A. HeLa cells were transfected with pHACDH1α (panels 1-3) or pHACDH1β 
(panels 4-6). Cells were co-stained with mouse α-HA (panels 1 and 4) and rabbit α-cyclin 
A (panels 2 and 5). In panels 3 and 6, the CDH1 (green; probed with α-HA) and cyclin A 
(red) fluorescent signals were overlaid by computer assistance. Co-localization is shown 
in yellow. The same fields are shown in panels 1-3 and 4-6. Bar, 20µm. The patterns 
shown in panels 3 and 6 are representative of 68% and 63%, respectively, of 200 
CDH1α-/CDH1β-expressing cells. 
 
Figure 6  Peptide sequences encoded by exons 6 and 7 of human CDH1α target 
heterologous GFP protein to the nucleus. HeLa cells were transfected with pEGFP-C1 
(panel 1) or pEGFPE67 (panel 2). Unfixed cells were observed directly under the 
fluorescence microscope 24 hours after transfection. The same fields of the cells were 
also monitored by phase contrast microscopy (panel 1’ and 2’). Arrows indicate 
transfected cells. The pattern shown in panel 2 is representative of  62% of 200 GFPE67-
expressing cells. Bar, 20µm. 
 
Figure 7  Differential activity of human CDH1α and CDH1β in Xenopus embryos.  
(A) Representative images of embryos. (B) Graphic quantitation of post-MBT cell cycle 
arrest phenotype induced by expression of CDH1α. One blastomere of the 2-cell stage 
embryos was uninjected (uninj.; panel 1), mock-injected with PBS (mock; panel 2) or 
injected separately with 4µg of the indicated RNAs: Xenopus CDH1 (XCDH1), human 
CDH1α  (HCDH1α, panel 3), human CDH1β (HCDH1β, panel 4), antisense human 
CDH1α (as-HCDH1α), or antisense human CDH1β (as-HCDH1β). For each 
determination thirty embryos were counted. Each bar represents the average values from 
three experiments. Images in A were photographed at stage 8.5-9.5. The arrow indicates 
the arrested large cells on the injected side.  







